Bortezomib liquid Spirig HC 3.5 mg/1.4 ml, Injektionslösung
7680674210016
CH-67421
Injektionslösung
Associated product:
BORTEZOMIB LIQUID Spirig HC 3.5 mg/1.4 ml sol inj
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
bortezomibum
|
3.5 MG | Substance | Wirkstoff (Principe actif) |
|
mannitolum
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrium
|
4.96 MG | Substance | HBESI |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 421.85
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/02/2020
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 67421
- Drug name
- Bortezomib liquid Spirig HC, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- L01XG01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 09/12/2019
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- BORTEZOMIB LIQUID Spirig HC 3.5 mg/1.4 ml sol inj
- Description (DE)
- BORTEZOMIB LIQUID Spirig HC 3.5 mg/1.4 ml Inj Lös
- Market launch
- 09/12/2019
- Narcotic (BTM)
- No
Original drug
Velcade, Lyophilisat zur Herstellung einer Injektionslösung
GTIN: 7680569760015
CHF 460.10
Other package sizes (1)
BORTEZOMIB LIQUID Spirig HC 7 mg/2.8 ml sol inj
1 DUR
GTIN: 7680674210023